Christopher Causey is of UNITED THERAPEUTICS Corp. Currently has a direct ownership of 3,675 shares of UTHR, which is worth approximately $1.32 Million. The most recent transaction as insider was on Nov 01, 2024, when has been sold 510 shares (Common Stock) at a price of $376.63 per share, resulting in proceeds of $192,081. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 3.68K
12.19% 3M change
12.19% 12M change
Total Value Held $1.32 Million

CHRISTOPHER CAUSEY Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 01 2024
SELL
Open market or private sale
$192,081 $376.63 p/Share
510 Reduced 12.19%
3,675 Common Stock
Aug 21 2024
SELL
Open market or private sale
$422,290 $349.0 p/Share
1,210 Reduced 22.43%
4,185 Common Stock
Aug 21 2024
BUY
Exercise of conversion of derivative security
$160,083 $132.3 p/Share
1,210 Added 18.32%
5,395 Common Stock
Jun 18 2024
SELL
Open market or private sale
$912,540 $304.18 p/Share
3,000 Reduced 41.75%
4,185 Common Stock
Jun 18 2024
BUY
Exercise of conversion of derivative security
$336,420 $112.14 p/Share
3,000 Added 29.46%
7,185 Common Stock
Jun 13 2024
SELL
Open market or private sale
$563,060 $281.53 p/Share
2,000 Reduced 32.34%
4,185 Common Stock
Jun 13 2024
BUY
Exercise of conversion of derivative security
$224,280 $112.14 p/Share
2,000 Added 24.43%
6,185 Common Stock
May 15 2024
SELL
Open market or private sale
$545,800 $272.9 p/Share
2,000 Reduced 32.34%
4,185 Common Stock
May 15 2024
BUY
Exercise of conversion of derivative security
$224,280 $112.14 p/Share
2,000 Added 24.43%
6,185 Common Stock
May 03 2024
SELL
Open market or private sale
$582,198 $259.91 p/Share
2,240 Reduced 34.86%
4,185 Common Stock
May 03 2024
BUY
Exercise of conversion of derivative security
$251,193 $112.14 p/Share
2,240 Added 25.85%
6,425 Common Stock
Dec 15 2023
SELL
Open market or private sale
$102,000 $255.0 p/Share
400 Reduced 8.72%
4,185 Common Stock
Dec 12 2023
SELL
Open market or private sale
$749,040 $249.68 p/Share
3,000 Reduced 39.55%
4,585 Common Stock
Dec 12 2023
BUY
Exercise of conversion of derivative security
$526,290 $175.43 p/Share
3,000 Added 28.34%
7,585 Common Stock
Jul 07 2023
BUY
Exercise of conversion of derivative security
-
1,750 Added 27.62%
4,585 Common Stock
Jan 03 2023
SELL
Open market or private sale
$276,260 $276.26 p/Share
1,000 Reduced 26.08%
2,835 Common Stock
Jan 03 2023
BUY
Exercise of conversion of derivative security
$175,430 $175.43 p/Share
1,000 Added 20.68%
3,835 Common Stock
Nov 03 2022
SELL
Open market or private sale
$650,000 $260.0 p/Share
2,500 Reduced 46.86%
2,835 Common Stock
Nov 03 2022
BUY
Exercise of conversion of derivative security
$438,575 $175.43 p/Share
2,500 Added 31.91%
5,335 Common Stock
Nov 02 2022
SELL
Open market or private sale
$1,225,000 $245.0 p/Share
5,000 Reduced 63.82%
2,835 Common Stock
Nov 02 2022
BUY
Exercise of conversion of derivative security
$877,150 $175.43 p/Share
5,000 Added 48.38%
5,335 Common Stock
Aug 23 2022
SELL
Open market or private sale
$787,360 $224.96 p/Share
3,500 Reduced 55.25%
2,835 Common Stock
Aug 23 2022
BUY
Exercise of conversion of derivative security
$614,005 $175.43 p/Share
3,500 Added 35.59%
6,335 Common Stock
Jul 08 2022
BUY
Exercise of conversion of derivative security
-
2,160 Added 43.24%
2,835 Common Stock
Jun 27 2022
SELL
Open market or private sale
$1,183,950 $236.79 p/Share
5,000 Reduced 88.11%
675 Common Stock
CC

Christopher Causey

Silver Spring, MD

Track Institutional and Insider Activities on UTHR

Follow UNITED THERAPEUTICS Corp and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells UTHR shares.

Notify only if

Insider Trading

Get notified when an United Therapeutics Corp insider buys or sells UTHR shares.

Notify only if

News

Receive news related to UNITED THERAPEUTICS Corp

Track Activities on UTHR